Zeposia’s Ulcerative Colitis Approval Provides BMS’s Beachhead Into GI

 
• By Joseph Haas
  
FDA approved background, 3D rendering, blue street sign
Ulcerative colitis is Zeposia's second US indication
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip